Skip Nav Destination
1-20 of 139
Keywords: Benign prostatic hyperplasiaClose
Fabio Crocerossa, Francesco Cantiello, Lorenzo Bagalá, Francesco Sicoli, Umberto Carbonara, Celeste Manfredi, Ugo Falagario, Alessandro Veccia, Savio D. Pandolfo, Luigi Napolitano, Matteo Ferro, Michele Di Dio, Nicola Mondaini, Rocco Damiano
Urol Int 1–11.
Published Online: 08 November 2023
...Fabio Crocerossa; Francesco Cantiello; Lorenzo Bagalá; Francesco Sicoli; Umberto Carbonara; Celeste Manfredi; Ugo Falagario; Alessandro Veccia; Savio D. Pandolfo; Luigi Napolitano; Matteo Ferro; Michele Di Dio; Nicola Mondaini; Rocco Damiano Introduction: Benign prostatic hyperplasia (BPH...
Ran Katz, Muhamad Sabih Abu Ahmed, Ali Safadi, Shmuel Roizman, Amnon Zisman, Maharan Kabha, Yoram Dekel, Jack Baniel, Shachar Aharony
Urol Int (2023) 107 (4): 406–412.
Published Online: 02 May 2023
... symptoms. We assessed its safety, efficacy and impact on urinary flow, ejaculation, and quality of life. Materials and Methods: We included 64 men, treated for benign prostate hyperplasia for at least 1 year. All patients had Qmax≤ 13 mL/s and IPSS >12. Insertion of the device was performed via...
Urol Int (2023) 107 (4): 358–362.
Published Online: 02 May 2023
...Atanas Ivanov; Petar Antonov; Eleonora Hristova-Atanasova; Petar Uchikov Introduction: Benign prostatic hyperplasia (BPH) is a histological diagnosis characterized by an increase in the number of epithelial and stromal cells in the transitional zone of the prostate gland. The clinical manifestation...
Urol Int (2023) 107 (2): 111–125.
Published Online: 22 March 2023
...Fulin Zhang; Jinbin Xu; Ciming Sun; Fuyang Dai; Qin Zhu; Hui Liang Background: Benign prostatic hyperplasia (BPH) is a common urological disorder leading to dysuria in middle-aged and elderly men and significantly reduces the quality of life of patients. Technology for BPH has made a great progress...
Saddam H. Al Demour, Mohannad Abuhamad, Abdallah Nader Santarisi, Mohammad Al-Zubi, Samer Fathi Al-Rawashdah, Omar Halalsheh, Antonio Carbone, Antonio Luigi Pastore, Muayyad M. Ahmad
Urol Int (2022) 106 (10): 997–1004.
Published Online: 02 June 2022
... from any ideas, methods, instructions or products referred to in the content or advertisements. Sexual function Erectile function Ejaculation function Benign prostatic hyperplasia Transurethral resection of prostate Lower urinary tract symptoms Lower urinary tract symptoms (LUTS...
Urol Int (2022) 106 (10): 1012–1017.
Published Online: 29 November 2021
...Diaa-Eldin Taha; Ali Ibrahim; Mona Talaat; Tarek Abdelbaky; Hossam Nabeeh Objectives: The aim of this study was to assess whether the duration of preoperative benign prostatic hyperplasia (BPH) medication would affect the pressure flow study (PFS) parameters and the outcome of prostate surgery...
Angelo Porreca, Michele Colicchia, Alessandro Tafuri, Daniele D’Agostino, Gian Maria Busetto, Alessandro Crestani, Katia Odorizzi, Nelia Amigoni, Riccardo Rizzetto, Alessandra Gozzo, Sebastian Gallina, Lorenzo Bianchi, Matteo Ferro, Roberto Falabella, Daniele Romagnoli, Alessandro Antonelli, Paolo Corsi, Riccardo Schiavina
Urol Int (2022) 106 (10): 979–991.
Published Online: 21 September 2021
... ). The key terms used were as follows: ([HoLEP] AND [HoLEP OR Holmium Laser Enucleation of the Prostate] AND [complication OR outcome] AND [benign prostatic hyperplasia OR benign prostatic enlargement OR LUTS OR lower urinary tract symptoms]). The terms “complication” and “adverse events” and “enucleation...
Matteo Massanova, Sophie Robertson, Biagio Barone, Lorenzo Dutto, Vincenzo Francesco Caputo, Jaimin R. Bhatt, Imran Ahmad, Maida Bada, Alison Obeidallah, Felice Crocetto
Urol Int (2021) 105 (9-10): 804–810.
Published Online: 09 July 2021
.... Magnetic resonance imaging Transrectal ultrasound Benign prostatic hyperplasia Digital rectal examination Prostate-specific antigen Prostate volume In order to correctly evaluate and manage prostatic diseases, such as benign prostatic hypertrophy (BPH) and prostate cancer (PCa...
Urol Int (2021) 105 (9-10): 852–857.
Published Online: 29 March 2021
.... Holmium laser enucleation of the prostate Benign prostatic hyperplasia Transrectal prostate biopsy High-power holmium laser enucleation of the prostate Transurethral enucleation Holmium laser enucleation of the prostate (HoLEP) is the gold standard treatment for benign prostatic hyperplasia...
Urol Int (2021) 105 (9-10): 817–825.
Published Online: 09 March 2021
... frequency, time to first awakening, nighttime voided volume, IPSS 7 (nighttime frequency), and IPSS QOL. Table 3. Test result of interaction of outcomes by the mixed model for testosterone level (<4.8 vs. ≥4.8 ng/mL) (0 W vs. 36 + 52 W) Anticholinergics Benign prostatic hyperplasia...
Jian Zhang, Yonghui Wang, Shuang Li, Shipeng Jin, Shiqing Zhang, Chunli Zhao, Wenzeng Yang, Shujin Cui, Yuexin Liu
Urol Int (2021) 105 (9-10): 735–742.
Published Online: 01 February 2021
...Jian Zhang; Yonghui Wang; Shuang Li; Shipeng Jin; Shiqing Zhang; Chunli Zhao; Wenzeng Yang; Shujin Cui; Yuexin Liu Background: Benign prostatic hyperplasia (BPH) is a common chronic progressive disease resulting in urinary obstruction in aging men. It comes to more and more patients with massive...
Urol Int (2021) 105 (9-10): 811–816.
Published Online: 28 January 2021
... and as surrogate markers for metabolic disease, cardiovascular disease, and malignancies, including prostate cancer. However, scant studies have investigated the association of NLR, PLR, and LMR with benign prostatic hyperplasia (BPH). Methods: Data from 8,727 middle-aged men who had participated in a health...
Urol Int (2021) 105 (7-8): 541–547.
Published Online: 28 January 2021
..., particularly in middle-aged and older men. BOO can occur due to bladder neck obstruction or benign prostatic hyperplasia (BPH). Gratzke et al. [ 32 ] reported that dialysis duration >120 months and age over 60 years were associated with significantly higher risk of urinary retention. Early detection...
Kadir Omur Gunseren, Serkan Akdemir, Mehmet Cagatay Çiçek, Ali Yıldız, Murat Arslan, İsmet Yavaşcaoğlu, Hakan Vuruskan
Urol Int (2021) 105 (3-4): 285–290.
Published Online: 23 November 2020
... records of patients with 80-g or larger prostates who underwent holmium laser enucleation of the prostate (HoLEP), laparoscopic simple prostatectomy (LSP), or open prostatectomy (OP) due to medical treatment-resistant benign prostatic hyperplasia (BPH) were reviewed retrospectively. Patients were...
Ibrahim Karabulut, Ahmet Emre Cinislioglu, Nazan Cinislioglu, Fatih Kursat Yilmazel, Mustafa Utlu, Handan Alay, Erkan Cem Celik, Senol Adanur
Urol Int (2020) 104 (11-12): 853–858.
Published Online: 07 September 2020
...Ibrahim Karabulut; Ahmet Emre Cinislioglu; Nazan Cinislioglu; Fatih Kursat Yilmazel; Mustafa Utlu; Handan Alay; Erkan Cem Celik; Senol Adanur Purpose: To investigate the effectiveness of benign prostatic hyperplasia (BPH)-related lower urinary tract symptoms (LUTS), which occur as a natural result...
Ryosuke Takahashi, Yasuhiro Sumino, Minoru Miyazato, Hisae Nishii, Takuma Oshiro, Hiromitsu Mimata, Seiichi Saito, Masaki Yoshida, Masatoshi Eto
Urol Int (2020) 104 (7-8): 587–593.
Published Online: 07 August 2020
... of life (QoL) is still unknown. Objective: The effects of tadalafil on nocturia and nocturia-related QoL were evaluated prospectively in patients with benign prostatic hyperplasia (BPH) as a multicenter study. Methods: Eligible men were ≥40 years with nocturia ≥2 and a prostate volume ≥20 mL. Patients...
Klaus Eredics, Christine Meyer, Tanja Gschliesser, Branimir Lodeta, Ortwin Heissler, Thomas Kunit, Stephan Madersbacher
Urol Int (2020) 104 (5-6): 367–372.
Published Online: 11 June 2020
... Geriatric assessment Benign prostatic hyperplasia Lower urinary tract symptoms The ever-increasing older population is one of the major challenges in medicine. Austria (total population: 8.3 million) currently has 414,000 inhabitants aged 80 years or older, and this number will increase to 639,000...
Urol Int (2020) 104 (5-6): 351–355.
Published Online: 05 December 2019
... urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Methods: Between February 2018 and February 2019, men with symptomatic BPH (IPSS ≥10) were prospectively recruited. This prospective, open-label, 12-month study included two different protocols: (1) group A, SR 320 mg/day + BC...
Urol Int (2019) 103 (4): 439–443.
Published Online: 25 September 2019
...Yoshihisa Matsukawa; Tsuyoshi Majima; Shun Takai; Yasuhito Funahashi; Masashi Kato; Momokazu Gotoh Introduction: To determine the pre-treatment factors related to the improvement of overactive bladder (OAB) symptom after alpha-1 blocker monotherapy in patients with benign prostatic hyperplasia...
Urol Int (2019) 103 (2): 180–186.
Published Online: 30 April 2019
.... Objectives: The study aim was to evaluate the IPP effect in patients with benign prostatic hyperplasia. Method: This study included patients with ( n = 119) and without ( n = 121) IPP. The age, International Prostate Symptom Score (IPSS), PSA level, maximum and average flow rates, PV, hematuria, urinary...